| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.24B | 2.31B | 2.07B | 1.79B | 1.44B |
| Gross Profit | 484.67M | 579.89M | 501.74M | 424.81M | 269.64M |
| EBITDA | 173.46M | 247.66M | 211.83M | 159.46M | -25.84M |
| Net Income | 100.73M | 143.23M | 104.18M | 75.51M | -93.53M |
Balance Sheet | |||||
| Total Assets | 2.00B | 2.00B | 1.97B | 1.75B | 1.74B |
| Cash, Cash Equivalents and Short-Term Investments | 439.54M | 339.44M | 376.79M | 307.08M | 252.68M |
| Total Debt | 22.58M | 46.06M | 74.77M | 137.24M | 164.59M |
| Total Liabilities | 690.09M | 732.00M | 772.01M | 617.98M | 644.28M |
| Stockholders Equity | 1.38B | 1.32B | 1.25B | 1.18B | 1.14B |
Cash Flow | |||||
| Free Cash Flow | 179.75M | 35.34M | 168.03M | 104.74M | -143.42M |
| Operating Cash Flow | 210.13M | 113.13M | 228.66M | 129.75M | -98.65M |
| Investing Cash Flow | -30.30M | -69.52M | -53.28M | -23.64M | -38.79M |
| Financing Cash Flow | -92.46M | -86.45M | -103.41M | -45.39M | -8.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$575.78M | 6.61 | 7.43% | 10.87% | -3.14% | -29.66% | |
66 Neutral | HK$19.56B | 24.23 | 42.05% | 2.53% | 35.28% | 41.20% | |
64 Neutral | HK$3.28B | 12.04 | 6.65% | 5.90% | 8.92% | 9.50% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | HK$31.25B | 11.55 | 11.65% | 5.36% | 1.76% | 10.34% | |
48 Neutral | HK$951.00M | 92.72 | -12.38% | ― | 52.36% | ― | |
44 Neutral | HK$18.52B | -43.19 | -4.30% | 5.00% | -1.71% | 53.04% |